Are you Dr. Kay?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 54 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
4340 W Newberry Rd
Ste 202
Gainesville, FL 32607Phone+1 352-371-2800Fax+1 352-378-7009- Is this information wrong?
Summary
- Dr. Christine Kay, MD is a board certified ophthalmologist in Gainesville, Florida. She is currently licensed to practice medicine in Florida and Iowa. She is affiliated with North Florida/South Georgia Veteran's Health System and is an Assistant Professor at University of Florida College of Medicine.
Education & Training
- University of South Florida MorsaniResidency, Ophthalmology, 2006 - 2009
- Carilion Clinic-Virginia Tech Carilion School of MedicineInternship, Transitional Year, 2005 - 2006
- University of Florida College of MedicineClass of 2005
- University of Iowa Hospitals and ClinicsResidency, Ophthalmology
Certifications & Licensure
- FL State Medical License 2007 - 2026
- IA State Medical License 2009 - 2011
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Clinical and Genetic Characterization of Individuals With Achromatopsia Start of enrollment: 2013 Jun 01
- Vascular Reparative Mechanism in Diabetes Start of enrollment: 2011 Oct 30
- Safety and Efficacy Trial of AAV Gene Therapy in Patients With CNGA3 Achromatopsia (A Clarity Clinical Trial) Start of enrollment: 2017 Aug 03
- Join now to see all
Publications & Presentations
PubMed
- Assessment of Visual Function With Cotoretigene Toliparvovec in X-Linked Retinitis Pigmentosa in the Randomized XIRIUS Phase 2/3 Study.Panda, S., Gow, J., Zhao, G., MacLaren, R., , Lam, B., Pennesi, M., Kay, C.> ;Ophthalmology. 2024 Feb 27
- 1 citationsOvercoming the Challenges to Clinical Development of X-Linked Retinitis Pigmentosa Therapies: Proceedings of an Expert Panel.David G Birch, Janet K Cheetham, Stephen P Daiger, Carel Hoyng, Christine Kay, Ian M MacDonald, Mark E Pennesi, Lori S Sullivan> ;Translational Vision Science & Technology. 2023 Jun 1
- Development of Novel Patient-Reported Outcome (PRO) and Observer-Reported Outcome (ObsRO) Instruments in Retinitis Pigmentosa (RP) and Leber Congenital Amaurosis (LCA)...Isabelle Audo, Francesco Patalano, Christel Naujoks, Claudio Spera, M Dominik Fischer, Jane Green, Christine Kay, Todd Durham, Nicola Williamson, Helena Bradley, Melis...> ;Ophthalmology and Therapy. 2023 Aug 1
- Join now to see all
Authored Content
- Retinal Gene Therapies in Clinical TrialsMarch 2019
Press Mentions
- Atsena Therapeutics Announces Positive 6-Month Data from Ongoing Phase I/II Clinical Trial of ATSN-101 in Patients with Leber Congenital Amaurosis Caused by Biallelic Mutations in GUCY2D (LCA1)April 25th, 2023
- Atsena Therapeutics Announces Positive Results from Phase I/II Clinical Trial of ATSN-101 for the Treatment of GUCY2D-Associated Leber Congenital Amaurosis (LCA1)October 3rd, 2022
- Will Gene Therapy Comeback Last? Scientists Try to Make It SaferMay 31st, 2022
- Join now to see all
Hospital Affiliations
- North Florida/South Georgia Veteran's Health SystemGainesville, Florida